semaglutide for bmi 25 Oral Wegovy approved obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) Wegovy (semaglutide), a glucagon-like peptide-1
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6



















